230 related articles for article (PubMed ID: 21712361)
1. Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance.
Bhonagiri P; Pattar GR; Habegger KM; McCarthy AM; Tackett L; Elmendorf JS
Endocrinology; 2011 Sep; 152(9):3373-84. PubMed ID: 21712361
[TBL] [Abstract][Full Text] [Related]
2. Hexosamine biosynthesis pathway flux contributes to insulin resistance via altering membrane phosphatidylinositol 4,5-bisphosphate and cortical filamentous actin.
Bhonagiri P; Pattar GR; Horvath EM; Habegger KM; McCarthy AM; Elmendorf JS
Endocrinology; 2009 Apr; 150(4):1636-45. PubMed ID: 19036880
[TBL] [Abstract][Full Text] [Related]
3. Fat-induced membrane cholesterol accrual provokes cortical filamentous actin destabilisation and glucose transport dysfunction in skeletal muscle.
Habegger KM; Penque BA; Sealls W; Tackett L; Bell LN; Blue EK; Gallagher PJ; Sturek M; Alloosh MA; Steinberg HO; Considine RV; Elmendorf JS
Diabetologia; 2012 Feb; 55(2):457-67. PubMed ID: 22002007
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of phosphatidylinositol 4,5-bisphosphate against cortical filamentous actin loss and insulin resistance induced by sustained exposure of 3T3-L1 adipocytes to insulin.
Chen G; Raman P; Bhonagiri P; Strawbridge AB; Pattar GR; Elmendorf JS
J Biol Chem; 2004 Sep; 279(38):39705-9. PubMed ID: 15277534
[TBL] [Abstract][Full Text] [Related]
5. An early, reversible cholesterolgenic etiology of diet-induced insulin resistance.
Covert JD; Grice BA; Thornburg MG; Kaur M; Ryan AP; Tackett L; Bhamidipati T; Stull ND; Kim T; Habegger KM; McClain DA; Brozinick JT; Elmendorf JS
Mol Metab; 2023 Jun; 72():101715. PubMed ID: 37019209
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol 4,5-bisphosphate reverses endothelin-1-induced insulin resistance via an actin-dependent mechanism.
Strawbridge AB; Elmendorf JS
Diabetes; 2005 Jun; 54(6):1698-705. PubMed ID: 15919791
[TBL] [Abstract][Full Text] [Related]
7. Loss of cortical actin filaments in insulin-resistant skeletal muscle cells impairs GLUT4 vesicle trafficking and glucose transport.
McCarthy AM; Spisak KO; Brozinick JT; Elmendorf JS
Am J Physiol Cell Physiol; 2006 Nov; 291(5):C860-8. PubMed ID: 16774991
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance.
Horvath EM; Tackett L; McCarthy AM; Raman P; Brozinick JT; Elmendorf JS
Mol Endocrinol; 2008 Apr; 22(4):937-50. PubMed ID: 18165437
[TBL] [Abstract][Full Text] [Related]
9. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
10. Hexosamine biosynthesis impairs insulin action via a cholesterolgenic response.
Penque BA; Hoggatt AM; Herring BP; Elmendorf JS
Mol Endocrinol; 2013 Mar; 27(3):536-47. PubMed ID: 23315940
[TBL] [Abstract][Full Text] [Related]
11. Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation.
Traxinger RR; Marshall S
J Biol Chem; 1991 Jun; 266(16):10148-54. PubMed ID: 2037571
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance.
Marshall S; Bacote V; Traxinger RR
J Biol Chem; 1991 Mar; 266(8):4706-12. PubMed ID: 2002019
[TBL] [Abstract][Full Text] [Related]
13. Hexosamines are unlikely to function as a nutrient-sensor in 3T3-L1 adipocytes: a comparison of UDP-hexosamine levels after increased glucose flux and glucosamine treatment.
Bosch RR; Pouwels MJ; Span PN; Olthaar AJ; Tack CJ; Hermus AR; Sweep CG
Endocrine; 2004 Feb; 23(1):17-24. PubMed ID: 15034192
[TBL] [Abstract][Full Text] [Related]
14. Effects of overexpression of glutamine:fructose-6-phosphate amidotransferase (GFAT) and glucosamine treatment on translocation of GLUT4 in rat adipose cells.
Chen H; Ing BL; Robinson KA; Feagin AC; Buse MG; Quon MJ
Mol Cell Endocrinol; 1997 Nov; 135(1):67-77. PubMed ID: 9453242
[TBL] [Abstract][Full Text] [Related]
15. Glucose-induced insulin resistance of phosphatidylinositol 3'-OH kinase and AKT/PKB is mediated by the hexosamine biosynthesis pathway.
Singh LP; Gennerette D; Simmons S; Crook ED
J Diabetes Complications; 2001; 15(2):88-96. PubMed ID: 11274905
[TBL] [Abstract][Full Text] [Related]
16. Chromium enhances insulin responsiveness via AMPK.
Hoffman NJ; Penque BA; Habegger KM; Sealls W; Tackett L; Elmendorf JS
J Nutr Biochem; 2014 May; 25(5):565-72. PubMed ID: 24725432
[TBL] [Abstract][Full Text] [Related]
17. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues.
Virkamäki A; Daniels MC; Hämäläinen S; Utriainen T; McClain D; Yki-Järvinen H
Endocrinology; 1997 Jun; 138(6):2501-7. PubMed ID: 9165041
[TBL] [Abstract][Full Text] [Related]
18. TRIB3 mediates glucose-induced insulin resistance via a mechanism that requires the hexosamine biosynthetic pathway.
Zhang W; Liu J; Tian L; Liu Q; Fu Y; Garvey WT
Diabetes; 2013 Dec; 62(12):4192-200. PubMed ID: 23990361
[TBL] [Abstract][Full Text] [Related]
19. The hexosamine biosynthetic pathway induces gene promoter activity of acetyl-CoA carboxylase beta.
Imbriolo J; Mapanga RF; Essop MF
Biochem Biophys Res Commun; 2014 Sep; 452(3):734-9. PubMed ID: 25195817
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance.
Tang J; Neidigh JL; Cooksey RC; McClain DA
Diabetes; 2000 Sep; 49(9):1492-9. PubMed ID: 10969833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
